Evidence map›Paper›PMID 35522920›Full record

ArticleBiomedical instrumentation & technology2022

Aluminum Leaching from Fluid Warmers: Regulatory Deferral to Clinicians' Decision.

Marko Oydanich, Rotem Naftalovich, Patrick J Discepola, Jim Doran, Faraz A Chaudhry, Daniel J Eloy

Abstract read
In one paragraph

Article in Biomedical instrumentation & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marko OydanichMarko Oydanich, MS, is a medical student at Rutgers New Jersey Medical School in Newark, NJ. Email: mko36@gsbs.rutgers.edu.
Rotem NaftalovichRotem Naftalovich, MD, MBA, is head of neurosurgical anesthesia at Rutgers New Jersey Medical School in Newark, NJ, and a Captain in the Medical Corps of the U.S. Army, Fort Sam Houston, TX. Email: naftalro@njms.rutgers.edu.
Patrick J DiscepolaPatrick J. Discepola, MD, is the director of regional anesthesia at Rutgers New Jersey Medical School in Newark, NJ. Email: disceppj@njms.rutgers.edu.
Jim DoranJim Doran, CRNA, is a clinical instructor at Rutgers New Jersey Medical School and the chief CRNA at University Hospital in Newark, NJ. Email: doranja@uhnj.org.
Faraz A ChaudhryFaraz Chaudhry, MD, is the director of clinical operations at Rutgers New Jersey Medical School in Newark, NJ. Email: chaudhfa@njms.rutgers.edu.
Daniel J EloyJean Daniel Eloy, MD, is vice-chair for clinical research at Rutgers New Jersey Medical School in Newark, NJ. Email: eloyje@njms.rutgers.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluid-warming systems are crucial in surgical and trauma settings because of their key role in preventing or treating hypothermia and enabling proper resuscitation of blood products that are stored cold. Recently, several manufacturers have issued warnings of the possibility of aluminum leaching from their fluid warmers and cautioned about the potential for aluminum toxicity in patients who underwent fluid resuscitation with these devices. Studies suggest that one of the main factors affecting aluminum leaching in this setting is the coating of the aluminum plate itself. Coating, often with a biocompatible material, appears to reduce aluminum leaching by 100- to 200-fold compared with an uncoated plate. Nonetheless, leaching with the coating is still at a level exceeding U.S. regulations. A few aluminum-free warming systems are available on the market, but these are not carried by all providers and some clinicians may be less familiar with their use. Medical device manufacturers will likely design future warming systems with less potential for aluminum blood contact. In the meantime, the risk of inadequate resuscitation, consequent to the proper fluid warmer no longer being available, is contrasted with the risk of potential toxicity. In the situation described here, the regulators deferred the ultimate decision of which fluid warmer to use in a given situation to the risk-benefit decision of the clinician.

Indexed as

AluminumHypothermiaHumansAluminum

Identifiers

PMID35522920
PMCPMC9767429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.